Show simple item record

dc.contributor.authorShah, Rubina
dc.contributor.authorAli, Faraz M
dc.contributor.authorNixon, Stuart J
dc.contributor.authorIngram, John R
dc.contributor.authorSalek, Sam M
dc.contributor.authorFinlay, Andrew Y
dc.date.accessioned2021-09-01T13:15:01Z
dc.date.available2021-09-01T13:15:01Z
dc.date.issued2021-05-25
dc.identifier.citationShah , R , Ali , F M , Nixon , S J , Ingram , J R , Salek , S M & Finlay , A Y 2021 , ' Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey ' , BMJ Open , vol. 11 , no. 5 , e047680 . https://doi.org/10.1136/bmjopen-2020-047680
dc.identifier.issn2044-6055
dc.identifier.otherJisc: 210cb1adcc604da88f58efb4ff36a516
dc.identifier.otherpublisher-id: bmjopen-2020-047680
dc.identifier.urihttp://hdl.handle.net/2299/25028
dc.description.abstractObjective: This study aimed to measure the impact of COVID-19 on the quality of life (QoL) of survivors and their partners and family members. Design and setting: A prospective cross-sectional global online survey using social media. Participants: Patients with COVID-19 and partners or family members (age ≥18 years). Intervention: Online survey from June to August 2020. Main outcome measure: The EuroQol group five dimensions three level (EQ-5D-3L) to measure the QoL of survivors of COVID-19, and the Family Reported Outcome Measure (FROM-16) to assess the impact on their partner/family member’s QoL. Results: The survey was completed by 735 COVID-19 survivors (mean age=48 years; females=563) at a mean of 12.8 weeks after diagnosis and by 571 partners and 164 family members (n=735; mean age=47 years; females=246) from Europe (50.6%), North America (38.5%) and rest of the world (10.9%). The EQ-5D mean score for COVID-19 survivors was 8.65 (SD=1.9, median=9; range=6–14). 81.1% (596/735) reported pain and discomfort, 79.5% (584/735) problems with usual activities, 68.7% (505/735) anxiety and depression and 56.2% (413/735) problems with mobility. Hospitalised survivors (20.1%, n=148) and survivors with existing health conditions (30.9%, n=227) reported significantly more problems with mobility and usual activities (pen
dc.format.extent710255
dc.language.isoeng
dc.relation.ispartofBMJ Open
dc.subjectPublic health
dc.subject1506
dc.subject2474
dc.subject1724
dc.subjectCOVID-19
dc.subjectpublic health
dc.subjectinfection control
dc.titleMeasuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online surveyen
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1136/bmjopen-2020-047680
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record